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Background: Herpes simplex virus (HSV) infection is one of the commonest viral sexually transmitted infections
(STIs). The aim of this study was to evaluate the prevalence of STIs among HSV positive patients at a tertiary
hospital in Jeddah. Secondary objective of the study included the description of the demographic and clinical
profile of patients with HSV and HIV co-infection.
Methods: A retrospective chart review of the medical records was performed for HSV positive women who
presented to the emergency room and outpatient department of King Abdulaziz University Hospital, Jeddah, Saudi
Arabia between January 1, 2003 and August 30, 2011. Data were collected from the medical records of all the
patients and analyzed using the Statistical Package for the Social Sciences.
Results: Three hundred forty-three HSV positive patients were included in this study. Co-infection with HIV was
documented in 45 patients (13.1%). Other STIs included chlamydia (n = 43, 12.5%), gonorrhea (n = 44, 12.8%),
hepatitis B infection (n = 8, 2.3%), and cytomegalovirus infection (n = 37, 10.8%). Nineteen patients (5.5%) had a total
of 47 term pregnancies and five abortions post HSV diagnosis. Genital ulcer disease was diagnosed in 11 (57.9%) of
the cases during labor. One newborn developed neonatal herpes infection and subsequently showed delayed
psychomotor development during follow up. Genital herpes was diagnosed in one patient’s partner; however, there
was no documentation of screening for STIs in the partners of the other patients.
Conclusions: Sexually transmitted infections are relatively common among HSV positive patients at King Abdulaziz
University Hospital. Amongst these, HIV is the most common, with a prevalence of 13.1%. Further studies are
warranted to evaluate STIs in Saudi Arabia. Health policy makers should adopt a protocol to screen for STIs in the
partners of persons who are positive for any STI as early detection and appropriate treatment can improve the
outcome.
Keywords: Herpes simplex virus, HIV, Pregnancy, Fetal outcome, Sexually transmitted infectionsBackground
Sexually transmitted infections (STIs) are among the
most common under diagnosed health problems world-
wide, and are rapidly becoming a progressive threat to
society. In 2008, there were an estimated 110 million
prevalent STIs among women and men in the United
States [1]. Amongst these, herpes simplex virus (HSV)
infection was reported to be one of the commonest viral
STIs. Its incidence continues to rise, especially amongCorrespondence: fageeh.wafa@gmail.com
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reproduction in any medium, provided the orfemales in the reproductive age group [2]. In the Middle
East and North African countries, it was estimated that
about 9.6 million women aged 15–49 years had HSV
infection in 2003 [3]. However, data on other STIs,
such as chlamydia, gonorrhea, and syphilis are limited
in these countries.
In Saudi Arabia, data on HIV was published for the first
time in 2004 [4], and only few reports describe the pattern
of STIs in the Kingdom [5,6]. At present, no local studies
have been conducted to evaluate the prevalence of herpes
simplex virus type 2 (HSV-2); a cause of most genital her-
pes; and are almost always sexually transmitted. NeitherThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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herpes simplex virus type 1 (HSV-1), which has emerged
as the principal causative agent of genital herpes in some
developed countries as well as in the United States [7].
Many studies have confirmed an epidemiologic asso-
ciation between HSV-2 seroprevalence and HIV infec-
tion [8-10]. HSV-2 positive patients were found to have
an increased risk of acquiring HIV infection, which has
been explained by the disruption of the genital mucosa
in patients with genital ulcer disease or by decreased
immunity in HSV-2 positive persons [11]. Furthermore,
it was found that HIV positive patients who have genital
ulcers are highly infectious due to HIV shedding from
the ulcer site. These patients also tend to have high HIV
viral loads [12,13]. Growing data is now describing the
benefits of herpes suppression in individuals co-infected
with HIV and HSV-2, as herpes suppression lowers HIV
viral load even though it would not control HIV sexual
transmission [12,14].
Since herpes infection could be asymptomatic but po-
tentially harmful during pregnancy, it is crucial for health
care providers to take a good sexual history, especially
whenever symptoms or signs raise red flags. However, the
stigma associated with STIs, particularly in conservative
countries, causes health care providers to be reluctant in
taking an explicit sexual history. Hence, a diagnosis of
HSV is not reached quite as often as it should. On the one
hand, measures such as a more detailed sexual history
increase in early diagnosis of HSV infections, screening, as
well as proper disease counseling and education will result
in decreased disease-related hazards. Routine screening
alternatively could be unethical and not cost effective [9].
The purpose of this study is to evaluate the prevalence
of STIs among HSV positive patients at a tertiary hospital
in Jeddah, Saudi Arabia. Secondary objective was to de-
scribe the demographic and clinical profile of patients
with HSV and HIV co-infection.
Methods
A retrospective chart review of the medical records was
performed for HSV positive women who presented to
the emergency room and outpatient department of King
Abdulaziz University Hospital, Jeddah, Saudi Arabia
between January 1, 2003 and August 30, 2011.
A total of 406 patients from the initial pool of 546
patients were positive for IgG and / or IgM anti-HSV and/
or had a positive viral culture for HSV. Only women, who
accounted for 68.7% of all HSV positive cases, were in-
cluded in the study. The prevalence of positive to negative
test ratio in the study population was 3.8 : 1.
Data, including age, presenting complaints, results of
laboratory investigations, serious complications, and neo-
natal outcome in pregnant women were collected from the
medical records of all the patients included in the study.All cases of HSV infection were diagnosed mainly based
on clinical suspicion and confirmed by laboratory testing.
In all cases, type-specific antibodies to HSV-1 and HSV-2
were determined by an indirect enzyme-linked immuno-
sorbent assay (ELISA). In cases with active lesions, direct
detection methods for HSV were performed by viral culture
of vesicle fluid and ulcers. HIV cases were also diagnosed
based on clinical suspicion. Enzyme-linked immunosorbent
assays (R&D Systems Inc., Minneapolis, MN) were used for
the detection of HIV-1 and HIV-2. For cases which were
positive on ELISA, viral load was determined by highly sen-
sitive quantitative PCR assays. The diagnosis of other STIs,
such as syphilis, human papilloma virus infection, chla-
mydia, gonorrhea, and hepatitis B infection were similarly
done based on clinical suspicion and confirmed by labora-
tory testing. Syphilis was confirmed by rapid plasma regain,
human papilloma virus by PCR, chlamydia and gonorrhea
by culture, and hepatitis B by ELISA.
Statistical analysis
Data was analyzed using the Statistical Package for the
Social Sciences (SPSS Inc., Chicago, IL, USA). Descriptive
statistics of demographic data were performed. Results
were expressed as frequency (percent).
Permission to conduct the study was granted by the
Ethics Committee of King Abdulaziz University.
Results
Three hundred forty-three HSV positive patients were
included in this study. The mean ± SD age of the patients
was 33.5 ± 14.5 years (range, 5 days to 73 years). Of the 343
patients, 76 were Saudis (22.2%); 187 patients (54.5%) were
married. Forty-five (13.1%) of the 343 patients had HIV and
HSV co-infection. Their mean age was 33.1 ± 18.2 years.
Twenty-nine patients (64.4%) were Saudis. Thirty-three
(73.3%) were married, while 12 (26.6%) were single. The
mean viral load of the patients was 927009 ± 1.8. The mean
CD4 count was 543.1 ± 249.1 and CD8 count 1037 ± 110.0.
The frequency of other STIs are as shown in Table 1.
One hundred sixty-eight patients (49.0%) presented
with orofacial lesions, 55 (16.0%) had genital herpes,
52 (15.2%) had encephalitis, nine (2.6%) had cancer,
three (0.9%) had multiple sclerosis, and two (0.6%) had
systemic lupus erythematosus. Sixty-five patients had a
miscellaneous presentation.
Patients with HIV and HSV co-infection (n = 45)
presented with the following symptoms: fever (n = 17,
37.8%), myalgia (n = 6, 13.3%), arthralgia (n = 3, 6.7%), loss
of appetite (n = 7, 15.6%), nausea (n = 4, 8.9%), vomiting
(n = 14, 31.1%), diarrhea (n = 6, 13.3%), weight loss (n = 6,
13.3%), and abdominal pain (n = 11, 24.4%).
Herpes simplex infection was diagnosed in 19 (5.5%)
patients during pregnancy. These patients (n = 19; 5.5%)
had a total of 47 term pregnancies (mean, 2.4) and five
Table 1 Frequency of other sexually transmitted
infections in herpes simplex positive patients
Infection Frequency Percent
Hepatitis B 8 2.3
HIV 45 13.1
HPV 16 4.7
CMV IgG 39 11.3
Chlamydia 44 12.8
Gonorrhea 16 4.7
Abbreviations: CMV cytomegalovirus, HIV human immunodeficiency virus, HPV
human papillomavirus, HSV herpes simplex virus.
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diagnosed during labor in 11 (23.4%) of the 47 cases.
Of these, seven had vulval warts. Three (15.8%) patients
presented with genital ulcers during their first pregnancy.
None of the patients received antiviral treatment during
pregnancy or delivery.
Vaginal delivery was allowed in four of the eleven cases
with active lesions. The average duration of labor in these
patients was 5 hours and 5 minutes (range, 6 hours
30 minutes - 12 hours 10 minutes). Cesarean section
was performed in the remaining seven cases. Indications
for cesarean section included breech presentation (n = 2),
twin pregnancy (n = 1), and active genital ulcers (n = 4).
Overall, there were two cases of intrauterine fetal death.
Two neonates were positive for HSV IgM antibodies;
however, after regular follow-up for two years, these
neonates had normal development. Two neonates de-
veloped herpetic skin eruption, but they did not show
any long-term complications. One newborn developed
neonatal herpes infection and subsequently showed
delayed psychomotor development during follow up.
Genital herpes was diagnosed in one patient’s partner;
however, there was no documentation of screening for
STIs in the partners of the other patients.
Among the patients with HIV and HSV co-infection,
13 (57.1%) died within one year of diagnosis. Only one
patient died during pregnancy.
Discussion
In a conservative country such as Saudi Arabia, it is con-
sidered a taboo to discuss STIs; hence, there are limited
data on the prevalence of HSV and other STIs. Local in-
formation about the prevalence of HSV and common STIs
are available from annually reported cases to the Ministry
of Health, and it is believed that the prevalence of HSV
infection is considerably underestimated [6]. This is mainly
because it is not obligatory to report HSV. More so, many
patients with HSV infection may not seek medical advice,
as awareness about HSV is markedly deficient [15].
In this study, we evaluated the prevalence of STIs, in-
cluding HIV, in HSV positive patients who were followedup at King Abdulaziz University Hospital. Our findings
demonstrated that 13.1% of HSV positive patients had HIV
co-infection. The prevalence of other STIs, namely hepa-
titis (2.3%), human papillomavirus (4.7%), cytomegalovirus
(11.3%), chlamydia (12.8%), and gonorrhea (4.7%) were
relatively low. This low prevalence is mainly because we
do not screen for STIs, and testing is restricted to patients
complaining of symptoms suggestive of an STI.
In a recent study, an estimated 22% of pregnant women
are reported to have HSV infection, and up to 80% of the
women who have genital herpes are unaware of being
infected [16]. In the current study, HSV infection was diag-
nosed in 5.5% of the women during pregnancy, and genital
herpes was diagnosed in 57.9% of the cases. Although
the incidence of HSV transmission from mother to
child is <1% even when the virus is detectable in the
maternal genital tract at the time of delivery [17], it is
imperative to diagnose the infection early, as delayed
diagnosis and initiation of therapy contributes to poor
neonatal outcome [18].
Overall, there were two cases of intrauterine fetal death,
two neonates developed herpetic skin eruption without
long-term complications, one case of neonatal herpes infec-
tion with subsequent delayed psychomotor development,
three cases of congenital anomaly, and five cases of abor-
tion. Even though intrauterine HSV infection is associated
with hydrops fetalis and fetal death, and surviving infants
of in utero HSV infection have symptoms at birth similar
to other congenital infections, other etiologies, namely
chlamydia, syphilis, hepatitis, and CMV infection, which
are associated with poor pregnancy and neonatal outcomes
[19-22], cannot be excluded.
According to the American College of Obstetricians
and Gynecologists, women with active recurrent genital
herpes should be offered suppressive viral therapy at or
beyond 36 weeks of gestation. Cesarean section should
be performed in women with active genital lesions or
symptoms, such as vulvar pain or burning at delivery,
because these symptoms may indicate an impending
outbreak [23]. However, none of our patients received
antiviral treatment during pregnancy or delivery. More
so, four of the patients with active disease were delivered
vaginally, and cesarean section was only performed in
four cases for active genital lesions. This may be due to
lack of awareness about STIs in both patients and health
care practitioners, as all cases of GUD were only diagnosed
during labor. In a conservative community such as ours,
partners of persons with STIs are usually not screened and
physicians do not take adequate sexual histories or perform
a complete physical examination. It is not uncommon for
women to try herbal treatment for infections, especially
when these involve the genitalia [24,25].
Data from the National AIDS Program of the Ministry
of Health in Saudi Arabia shows that the prevalence of
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limited data on the prevalence of HIV in hospital-based
studies, and two studies conducted in tertiary hospitals in
Riyadh reported a prevalence of zero percent among
Saudis and expatriates [27,28]. In the current study, HIV
infection was less frequent among non-Saudis. Given that it
is requirement of the Saudi authorities that all expatriates
entering the country undergo rigorous medical screening
for HIV and the hepatitis viruses, it is plausible that these
patients acquired HIV infection while in Saudi Arabia.
According to one report, the main mode of HIV trans-
mission in Saudi Arabia was heterosexual contact, and
most of the women in the study reportedly acquired the
infection either through blood transfusion or marital
sex with their infected husbands [5]. However, in other
cases with unidentifiable risk factors, it was suggested
that the patients acquired the infection through illegal
or non-marital sex [5].
Non-specific symptoms, such as fever, myalgia, vomiting,
diarrhea, and abdominal pain were common in our
patients with HSV and HIV co-infection. It has been
reported that primary infection may be complicated by
systemic symptoms, such as fever, headache, and myalgia
(38% in men, 68% in women) [29], and pre-existing
HSV-1 antibodies can alleviate clinical manifestations
of subsequently acquired HSV-2 [6]. Systemic clinical
findings may be the only presenting symptom of infection
in some patients, and in over half of the cases, primary
infection goes unnoticed [29].
Some limitations of our study warrant consideration.
First, it was limited by its retrospective nature. Second,
because of the difficulty in diagnosing chlamydia and
gonorrhea infection in women [30,31], some cases may
have been missed as no policy exists in our institution for
testing and diagnosing these infections. Third, the long
study period and the wide range of age of the patients
should be taken into consideration when interpreting the
results. Nonetheless, this study is the first to report the
prevalence of STIs among HSV positive patients at a
university hospital in Jeddah, Saudi Arabia.
Conclusions
Sexually transmitted infections are relatively common
among HSV positive patients at King Abdulaziz University
Hospital. Amongst these, HIV is the most common, with
a prevalence of 13.1%. Most patients with HSV and HIV
infection present with non-specific symptoms and therefore
diagnosis is mainly based on clinical suspicion contributing
to its underreporting.
Further studies are necessary to evaluate STIs in Saudi
Arabia. In order to provide appropriate treatment and
consequently minimize the spread of infection, suspected
cases should be screened for common STIs. Health policy
makers should also adopt a protocol to screen for STIs inthe partners of persons who are positive for any STI, as
early detection and appropriate treatment can improve
the outcome.
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